Bioprocess Online Covers 2026 ISPE Facility of the Year Awards (FOYA) Category Winner, Sanofi
17 July, 2026
Sanofi’s effort to replicate its pioneering “ballroom” biomanufacturing design across two continents has become a standout example of how global standardization can accelerate capacity, flexibility, and regulatory alignment in modern biologics production. As detailed in the article that follows by Bioprocess Online, the company built near identical Modulus facilities in Singapore and France, each engineered around a large, open, reconfigurable manufacturing space that replaces traditional fixed equipment suites. This approach allows Sanofi to rapidly switch between products, scale operations up or down, and integrate new technologies without major structural changes. The strategy also enabled regulators in different regions to rely on a shared design and validation package, reducing approval timelines and ensuring consistent quality expectations across markets.
This innovative, modular, and globally harmonized approach contributed to Sanofi’s recognition as a 2026 ISPE FOYA Category Winner in Innovation – Facility of the Future. This announcement was made during the 2026 ISPE Europe Annual Conference in Copenhagen, Denmark, where the company was honored, along with others, for redefining what a flexible, future ready biomanufacturing facility can be. The distinction underscores how the Modulus program sets a new benchmark for speed, agility, and regulatory efficiency in the biopharmaceutical sector.
The Overall FOYA Winner will be announced at the FOYA Banquet and Awards Celebration, taking place 18 October, during the 2026 ISPE Annual Meeting & Expo in Washington, D.C., USA .
Learn more about the 2026 ISPE FOYA Banquet and Awards Celebration
Learn more about the 2026 ISPE Annual Meeting & Expo
About Bioprocess Online
Bioprocess Online is part of the Life Science Connect media group. The publication provides technical information, industry knowledge, and content for the biotherapeutic community. Audiences include bioprocess engineers, scientists, bioprocessing managers, biotechnology producers, consultants, QA/QC, project managers, directors, purchasers, marketers, and those involved in biopharmaceutical supply chain or facilities management.